New 'Tumor-Activated' drug enters human testing for Tough-to-Treat cancers
Disease control
Recruiting now
This is the first study in people to test a new drug called XTX301 for advanced solid tumors. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for patients with cancers like lung, melanoma, or ovarian cancer that have spread or gotten worse desp…
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC